REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuroinnova S.A.S. (Ecuador)

Main Activities: Psychiatric and Substance Abuse Hospitals
Secondary Activities: Offices of Other Health Practitioners | Child and Youth Services
Full name: Neuroinnova S.A.S. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neuroinnova S.A.S. is an enterprise located in Ecuador, with the main office in Guayaquil. It operates in the Psychiatric and Substance Abuse Hospitals industry. The company was established on October 07, 2021. The total number of employees is currently 8 (2023). The company’s latest financial report indicates a net sales revenue increase of 148.97% in 2023. Its total assets grew by 46.18% over the same period. The net profit margin of Neuroinnova S.A.S. increased by 1.22% in 2023.

Headquarters
Na 205
Guayaquil; Guayas;

Contact Details: Purchase the Neuroinnova S.A.S. report to view the information.

Website: http://www.neuroinnova.com.ec/

Basic Information
Total Employees:
Purchase the Neuroinnova S.A.S. report to view the information.
Outstanding Shares:
Purchase the Neuroinnova S.A.S. report to view the information.
Registered Capital:
Purchase the Neuroinnova S.A.S. report to view the information.
Incorporation Date:
October 07, 2021
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Neuroinnova S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
148.97%
Total operating revenue
135.92%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
195.18%
Total assets
46.18%
Total equity
291.9%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
1.22%
Return on Equity (ROE)
-24.41%
Debt to Equity Ratio
-22.8%
Quick Ratio
0.4%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?